For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $145.36 in the prior trading day, Zoetis Inc (NYSE: ZTS) closed at $142.77, down -1.78%. In other words, the price has decreased by -$1.78 from its previous closing price. On the day, 2.75 million shares were traded. ZTS stock price reached its highest trading level at $146.15 during the session, while it also had its lowest trading level at $142.17.
Ratios:
Our goal is to gain a better understanding of ZTS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.51. For the most recent quarter (mrq), Quick Ratio is recorded 1.04 and its Current Ratio is at 1.76. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.09.
On June 18, 2025, Stifel Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $160.
On December 02, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $215.Leerink Partners initiated its Outperform rating on December 02, 2024, with a $215 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when Lagano Roxanne sold 652 shares for $170.00 per share. The transaction valued at 110,840 led to the insider holds 15,129 shares of the business.
Lagano Roxanne bought 652 shares of ZTS for $110,840 on Jun 03 ’25. On Mar 11 ’25, another insider, Reed Willie M, who serves as the Director of the company, bought 1,210 shares for $166.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 64421150720 and an Enterprise Value of 68638306304. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.56, and their Forward P/E ratio for the next fiscal year is 20.64. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.74 while its Price-to-Book (P/B) ratio in mrq is 12.74. Its current Enterprise Value per Revenue stands at 7.314 whereas that against EBITDA is 17.394.
Stock Price History:
The Beta on a monthly basis for ZTS is 0.90, which has changed by -0.24925065 over the last 52 weeks, in comparison to a change of 0.15927899 over the same period for the S&P500. Over the past 52 weeks, ZTS has reached a high of $196.55, while it has fallen to a 52-week low of $139.34. The 50-Day Moving Average of the stock is -4.45%, while the 200-Day Moving Average is calculated to be -9.90%.
Shares Statistics:
The stock has traded on average 3.09M shares per day over the past 3-months and 3184750 shares per day over the last 10 days, according to various share statistics. A total of 443.95M shares are outstanding, with a floating share count of 442.41M. Insiders hold about 0.18% of the company’s shares, while institutions hold 97.41% stake in the company. Shares short for ZTS as of 1757894400 were 9188089 with a Short Ratio of 2.97, compared to 1755216000 on 6601163. Therefore, it implies a Short% of Shares Outstanding of 9188089 and a Short% of Float of 2.07.
Dividends & Splits
In the trailing 12 months, ZTS’s forward annual dividend rate was 1.864, compared to 1.93 this year. Against a Trailing Annual Dividend Yield of 0.012823335. The stock’s 5-year Average Dividend Yield is 0.79.
Earnings Estimates
Its stock is currently analyzed by 12.0 different market analysts. The consensus estimate for the next quarter is $1.49, with high estimates of $1.53 and low estimates of $1.41.
Analysts are recommending an EPS of between $6.4 and $6.34 for the fiscal current year, implying an average EPS of $6.36. EPS for the following year is $6.88, with 18.0 analysts recommending between $7.11 and $6.61.
Revenue Estimates
11 analysts predict $2.41B in revenue for. The current quarter. It ranges from a high estimate of $2.44B to a low estimate of $2.38B. As of. The current estimate, Zoetis Inc’s year-ago sales were $2.39BFor the next quarter, 11 analysts are estimating revenue of $2.43B. There is a high estimate of $2.47B for the next quarter, whereas the lowest estimate is $2.39B.
A total of 16 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.55B, while the lowest revenue estimate was $9.46B, resulting in an average revenue estimate of $9.52B. In the same quarter a year ago, actual revenue was $9.26BBased on 16 analysts’ estimates, the company’s revenue will be $10.08B in the next fiscal year. The high estimate is $10.24B and the low estimate is $9.94B.
